Preclinical
Definition
Preclinical refers to the stage of research conducted before a compound enters human clinical trials. This phase encompasses in vitro (cell-based) studies, in vivo (animal model) experiments, and computational analyses designed to evaluate a compound’s safety, efficacy, pharmacokinetics, and mechanism of action.
Stages of Preclinical Research
Preclinical work typically progresses through several phases:
- Discovery and screening — Identifying candidate compounds through high-throughput assays, receptor binding studies, or rational design
- In vitro characterisation — Cell culture experiments to assess receptor affinity, selectivity, potency, and mechanism of action
- In vivo efficacy — Animal model studies evaluating whether the compound produces the desired biological effect
- Toxicology and safety — Assessing acute and chronic toxicity, off-target effects, and maximum tolerated dose
- Pharmacokinetics — Measuring absorption, distribution, metabolism, and excretion in animal models
Relevance to Peptide Research
The majority of research peptides featured on PeptideGuide are at the preclinical stage. This means their effects have been studied in laboratory settings but they have not yet completed human clinical trials for regulatory approval. Preclinical data provides valuable mechanistic insights but cannot be directly extrapolated to predict human outcomes. Understanding this distinction is essential for accurately interpreting peptide research literature.
Related Peptides
Peptide profiles that reference “Preclinical” in their research content.